戻る Agenda
Digital Risk Minimization: The “Next Generation” Risk Management Tools
Session Chair(s)
Meredith Yearsley Smith, PHD, MPA, FISPE
Fellow and faculty member
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States
This session will describe the process of conceptualizing, implementing, and evaluating digital risk minimization tools, using several real world examples. Join the Clinical Safety & Pharmacovigilance Community for a follow up Round Table discussion on Wednesday, June 26, 4:15-5:15PM in the DIA Community Zone 1, Sails Pavilion.
Learning Objective : Describe the process of developing a digital risk minimization tool; Outline considerations for the effective implementation and evaluation of a digital risk minimization tool.
Speaker(s)
Leveraging Digital for Effective Risk Minimization Tools: Operational and Policy Considerations
Simon Ingate, PHD, MBA
Axian Consulting Limited, United Kingdom
Engagement Manager
One Company's Perspective on Implementing Digital Risk Minimization Tools Globally
Sarah Frise, PHD, MS
AstraZeneca, Canada
Global Head Safety Epidemiology and Risk Management
Applying the Diffusion of Innovaton Theory Framework to the Implementation of Innovative Digital Risk Minimization Measures
Carmit Strauss, PHARMD
Takeda, United States
Executive Director, Head of Risk Management, Organ Toxicity and Benefit Risk